Increased Plasma YKL-40 Level and Chitotriosidase Activity in Cystic Fibrosis Patients
Authors:
- Dilara Bal TopcuDTDilara Bal Topcu
- Gokcen TugcuGTGokcen Tugcu
- Berrin ErBEBerrin Er
- Sanem Eryilmaz PolatSPSanem Eryilmaz Polat
- Mina HizalMHMina Hizal
- Ebru Elmas YalcinEYEbru Elmas Yalcin
- Deniz Dogru ErsozDEDeniz Dogru Ersoz
- Lutfi CopluLCLutfi Coplu
- Ugur OzcelikUOUgur Ozcelik
- Nural KiperNKNural Kiper
- Incilay LayILIncilay Lay
- Yesim OztasYOYesim Oztas
- 12 October 2021
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 45 (2) , 627-638
Abstract
We investigated plasma YKL-40 levels and chitotriosidase (CHIT1) activity in patients with cystic fibrosis (CF) lung disease and evaluated clinically relevant factors that may affect their levels. Plasma samples were obtained from pediatric (n = 19) and adult patients (n = 15) during exacerbation, discharge, and stable period of the disease. YKL-40 levels and chitotriosidase activity were measured by enzyme-linked immunosorbent assay and fluorometric assay, respectively. Data were compared with healthy children and adults of similar age. YKL-40 levels of pediatric and adult CF patients at all periods were significantly higher than controls (p < 0.001 and p < 0.05). CHIT1 activities of adult patients at all periods were significantly higher compared to controls (p < 0.05). On the other hand, CHIT1 activities of pediatric CF patients were similar with controls. YKL-40 levels of exacerbation period of adult CF patients were negatively correlated with forced vital capacity (FVC) (r = − 0.800, p = 0.014) and forced expiratory volume in 1 s (FEV1) (r = − 0.735, p = 0.008). YKL-40 levels in the exacerbation period of pediatric CF patients were negatively correlated with FVC (r = − 0.697, p = 0.0082) and FEV1 (r = − 0.720, p = 0.006). CHIT1 activity may be a valuable marker of chronic inflammation in adult CF patients who suffer from CF for a longer period compared to pediatric patients. Increased YKL-40 levels in both pediatric and adult patients compared to controls may point to a role in between CF pathology.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- The chitinase-like protein YKL-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthmaJournal of Allergy and Clinical Immunology, 2013
- The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung DiseasePLOS ONE, 2011
- New clinical diagnostic procedures for cystic fibrosis in EuropeJournal of Cystic Fibrosis, 2011
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and InjuryAnnual Review of Physiology, 2011
- Cystic fibrosisThe Lancet, 2009
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Clinical scoring systems in cystic fibrosisPediatric Pulmonology, 2006
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994